- Speed, Specificity, Cost-effectiveness & User-friendliness are some of the Key Buying Criteria in the Global Isothermal Nucleic Acid Amplification Technologies Market
TechNavio, the independent London-based global research firm, today announced the publication of its research report on the Global Isothermal Nucleic Acid Amplification Technologies (INAAT) Market. The report finds infectious disease diagnostics constitute more than 40 percent of the Global INAAT Market. The analysis is for the forecast period 2014-2018.
The market demand for infectious disease diagnosis is much higher due to the high incidence of various types of diseases across the world. In addition, the other parameters that increase the need for these tests in the market are the disability-adjusted life years lost per year and the huge economic burden due to infectious diseases. Some of the diseases targeted based on the INAAT platform include chlamydia, gonorrhea, HBV, HSV 1&2, HIV-1, HPV, and Trichomonas vaginalis.
High incidence of infectious diseases such as sexually transmitted diseases, hospital-acquired infections, and food-borne pathogens leading to high mortality rates is driving the Global INAAT market for Infectious Disease Diagnostics.
In 2013, the Infectious Disease Diagnostics segment held the largest share in the Global INAAT market, and this trend will be continuing during the forecast period owing to the demand for new diagnostic devices for many infectious diseases.
To determine the scenario for these vendors in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentation, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
If you are interested in more information on this topic and our upcoming research on the Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018, please send an e-mail to media@TechNavio.com
About TechNavio
TechNavio is a leading technology research and advisory company with a global coverage. We focus on emerging technology trends that can shape the market. We identify and explain these trends to our customers to help them take better decisions.
TechNavio models the trends using a mix of quantitative and qualitative tools in its proprietary research methodologies. We build forecasts across market segments and geographies based on the trends identified. These forecasts and analysis are used to help our customers identify new and existing opportunities in their markets. We also help customers assess their competitive position in a changing market scenario.
TechNavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape of Global Isothermal Nucleic Acid Amplification Technologies Market. Our analysts obtain the information using a combination of the bottom-up and top-down approaches, besides using in-house market modeling tools. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
Decision makers and influencers in sales & marketing, strategy, product and R&D teams rely on research from TechNavio. We have a large and growing base of happy customers worldwide. Our customers include technology suppliers, end users, consulting companies, investment firms and research institutes.
Founded in 2003, TechNavio has about 200 analysts globally. We cover more than 500 technologies across 80 countries. Our analysts are closely monitoring the market every day by talking to all the industry participants. We have proprietary databases that provide us with a complete perspective of the market. TechNavio develops over 2000 pieces of research deliverables every year.
Media Contact:
Rituparna Roy/Arijit Rakshit
Marketing Manager/Analyst & PR
+91 9591975898; +44 208 123 1770; +1 630 333 9501
Twitter: @TechNavio
